Abstract:Objectives: During the advancement of atherosclerosis, plaque cellularity is governed by the influx of monocyte-derived macrophages and their turnover via apoptotic and nonapoptotic forms of cell death. Previous reports have demonstrated that programmed necrosis, or necroptosis, of plaque macrophages contribute to necrotic core formation. Knockdown or inhibition of the necrosome components RIPK1 (receptor-interacting protein kinase 1) and RIPK3 (receptor-interacting protein kinase 3) slow atherogenesis, and activation of the terminal step of necroptosis, MLKL (mixed lineage kinase domain-like protein), has been demonstrated in advanced human atherosclerotic plaques. However, whether MLKL directly contributes to lesion development and necrotic core formation has not been investigated. Approaches and Results: MLKL expression was knocked down in atherogenic Apoe-knockout mice via the administration of antisense oligonucleotides. During atherogenesis, Mlkl knockdown decreased both programmed cell death and the necrotic core in the plaque. However, total lesion area remained unchanged. Furthermore, treatment with the MLKL antisense oligonucleotide unexpectedly reduced circulating cholesterol levels compared with control antisense oligonucleotide but increased the accumulation of lipids within the plaque and in vitro in macrophage foam cells. MLKL colocalized with the late endosome and multivesicular bodies in peritoneal macrophages incubated with atherogenic lipoproteins. Transfection with MLKL antisense oligonucleotide increased lipid localization with the multivesicular bodies, suggesting that upon Mlkl knockdown, lipid trafficking becomes defective leading to enhanced lipid accumulation in macrophages. Conclusions: These studies confirm the requirement for MLKL as the executioner of necroptosis, and as such a significant contributor to the necrotic core during atherogenesis. We also identified a previously unknown role for MLKL in regulating endosomal trafficking to facilitate lipid handling in macrophages during atherogenesis.

A necroptotic-independent function of MLKL in regulating endothelial cell adhesion molecule expression

Loss of MLKL (Mixed Lineage Kinase Domain-Like Protein) Decreases Necrotic Core but Increases Macrophage Lipid Accumulation in Atherosclerosis

The MLKL Channel in Necroptosis is an Octamer Formed by Tetramers in a Dyadic Process.

MLKL in cancer: more than a necroptosis regulator

Diverse sequence determinants control human and mouse receptor interacting protein 3 (RIP3) and mixed lineage kinase domain-like (MLKL) interaction in necroptotic signaling.

The molecular mechanisms of MLKL-dependent and MLKL-independent necrosis

Mixed Lineage Kinase Domain-Like Protein Promotes Human Monocyte Cell Adhesion to Human Umbilical Vein Endothelial Cells Via Upregulation of Intercellular Adhesion Molecule-1 Expression

Acylation of MLKL Impacts Its Function in Necroptosis

Translocation of mixed lineage kinase domain-like protein to plasma membrane leads to necrotic cell death

MLKL Attenuates Colon Inflammation and Colitis-Tumorigenesis Via Suppression of Inflammatory Responses

MLKL post-translational modifications: road signs to infection, inflammation and unknown destinations

The Many Faces of MLKL, the Executor of Necroptosis

Uncovering human mixed lineage kinase domain-like activation in necroptosis

Oligomerization-driven MLKL ubiquitylation antagonizes necroptosis

Activation of cell-surface proteases promotes necroptosis, inflammation and cell migration

Activated MLKL functions as signal II of the NLRP3 inflammasome

Necroptosis executioner MLKL plays pivotal roles in agonist-induced platelet prothrombotic responses and lytic cell death in a temporal order

Necrosome core machinery: MLKL

The brace helices of MLKL mediate interdomain communication and oligomerisation to regulate cell death by necroptosis

Inhibition of Non-Muscular Myosin Light Chain Kinase Accelerates the Clearance of Inflammatory Cells by Promoting the Lysosome-Mediated Cell Death

Mixed Lineage Kinase Domain-Like Protein MLKL Causes Necrotic Membrane Disruption Upon Phosphorylation by RIP3.